Lundbeck, LifeCycle Pharma, Lundbeck Foundation deal

Lundbeck sold its 27.1% stake in drug delivery company LifeCycle to the foundation's LFI A/S holding company for DKK18 per share, or about DKK275.6 million ($47.9 million). The price is a 49% premium ...